<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>T cell large granular lymphocyte <z:hpo ids='HP_0001909'>leukemia</z:hpo> (T-LGL) is characterised by semiautonomous proliferation of monoclonal cytotoxic T lymphocytes, which can result in <z:hpo ids='HP_0001875'>neutropenia</z:hpo>, <z:hpo ids='HP_0001744'>splenomegaly</z:hpo>, and is associated with various <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo>, particularly <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The coexistence of T-LGL <z:hpo ids='HP_0001909'>leukemia</z:hpo> with B cell abnormalities has previously been identified in case reports </plain></SENT>
<SENT sid="2" pm="."><plain>However, no systematic analysis to determine the frequency of this co-association has been reported </plain></SENT>
<SENT sid="3" pm="."><plain>Analysis of 63 T-LGL patients revealed a frequent association with humoral immune system abnormalities </plain></SENT>
<SENT sid="4" pm="."><plain>We identified coexisting B cell <z:e sem="disease" ids="C0334044" disease_type="Neoplastic Process" abbrv="">dyscrasias</z:e> in 17 T-LGL patients (27% of total), of whom 12 had <z:e sem="disease" ids="C0278494" disease_type="Neoplastic Process" abbrv="MGUS">monoclonal gammopathy of unknown significance</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MGUS</z:e>) (19%), and 5 had <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL) (8%) </plain></SENT>
<SENT sid="5" pm="."><plain>The presence of both <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MGUS</z:e> and CLL was found in 2 patients (3%) and follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was identified with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MGUS</z:e> in another T-LGL patient (2%) </plain></SENT>
<SENT sid="6" pm="."><plain>Additionally, polyclonal <z:hpo ids='HP_0010702'>hypergammaglobulinemia</z:hpo> or <z:hpo ids='HP_0004313'>hypogammaglobulinemia</z:hpo> was found in 10 additional LGL <z:hpo ids='HP_0001909'>leukemia</z:hpo> patients bringing the total frequency of B cell abnormalities in T-LGL <z:hpo ids='HP_0001909'>leukemia</z:hpo> to 43% in our cohort </plain></SENT>
<SENT sid="7" pm="."><plain>The co-association of B cell pathology with T-LGL suggests that either a common antigen drives clonal B and T cells, or that humoral <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> could serve as the stimulus for lymphocyte expansion representing an overactive anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> surveillance </plain></SENT>
</text></document>